Table 2. Clinical characteristics of the BUD group.
| Clinical parameter | Measurement | |
|---|---|---|
| Duration of disease* | N | 35 |
| Mean (range) in weeks | 3.4 (1–8) | |
| Lesion size | N | 31 |
| Mean surface (range) in cm2 | 22.1 (2.3–79.4) | |
| Mean volume (range) in cm3 | 0.59 (0–12) | |
| Lesion Category | Type I (< 5 cm**) N (%) | 16 (51.6) |
| Type II (< 15 cm**) N (%) | 14 (45.2) | |
| Type III (> 15 cm**) N (%) | 1 (3.2) | |
| Lesion type | N | 36 |
| Nodule N (%) | 18 (50.0) | |
| Oedema N (%) | 2 (5.6) | |
| Plaque N (%) | 5 (13.9) | |
| Ulcer N (%) | 11 (30.6) | |
| Time to healing (following start of antibiotic treatment) | N | 34 |
| Mean/Median (range) in days | 115.9/111.0 (14–337) | |
| fast ≤ 111 days N (%) | 17 (50%) | |
| slow > 111 days N (%) | 17 (50%) | |
| Rate of healing*** | N | 26 |
| Median (range) in mm/week | 0.44 (-0.94–1.8) |
* time between recognizing first symptoms and reporting at the hospital
** widest diameter
*** in the first 4 weeks